drugset / Trial / NCT01872039

Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

NCT01872039

Phase 4 Completed 163 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the efficacy and safety of two dose adjustment regimens (i.e. weight-based and non-weight-based) for the treatment of Chinese hypertensive emergency patients.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicardipine Small molecule

Indications

No indication recorded.